Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers

被引：4
|
作者：
Imai, Ryosuke [1 ]
Ikemura, Sumie [2 ]
Jinta, Torahiko [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, 9-1 Akashi Cho, Chuo City, Tokyo 1048560, Japan
[2] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan
来源：
RESPIROLOGY CASE REPORTS | 2021年 / 9卷 / 04期
关键词：
Dermatomyositis; durvalumab; immune checkpoint inhibitor; intravenous immunoglobulin;
D O I：
10.1002/rcr2.736
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We report a case of anti-transcriptional intermediary factor 1 gamma (TIF1 gamma) antibody-positive dermatomyositis following durvalumab treatment. The patient was successfully treated with pulse steroid therapy, high-dose intravenous immunoglobulin (IVIg), and tacrolimus. Durvalumab may induce dermatomyositis, and early diagnosis and aggressive therapy are crucial to prevent severe dermatomyositis, which is potentially treatable.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
    Ding, Yukang
    Ge, Yongpeng
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [42] Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis Associated With Multiple Heterologous Carcinomas: A Case Report
    Nakano, Yoshio
    Nishida, Koji
    Okamoto, Norio
    Gohma, Iwao
    Yasuhara, Yumiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [43] Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk
    Lv, Chengyin
    You, Hanxiao
    Xu, Lingxiao
    Wang, Lei
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Zhou, Shiliang
    Da, Zhanyun
    Qian, Jie
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Wang, Yan
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Wang, Fang
    Zhang, Miaojia
    Tan, Wenfeng
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (02) : 219 - 226
  • [44] Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
    Zhou, Shuang
    Lai, Jinzhi
    Wu, Chanyuan
    Liu, Yongtai
    Liu, Yingxian
    Zhao, Jiuliang
    Xu, Dong
    Tian, Xinping
    Li, Mengtao
    Zhao, Yan
    Wang, Yining
    Wang, Qian
    Zeng, Xiaofeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Cutaneous ulceration in dermatomyositis. Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status
    Wald, Caroline
    Simon, Jan-Christoph
    Treudler, Regina
    DERMATOLOGIE, 2025, 76 (02): : 97 - 100
  • [46] Plasma exchange for anti-MDA5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung disease: A case report and literature review
    Lu, Ci
    Xu, Cheng
    Zhu, Xiaoying
    Han, Yongmei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [47] The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
    Oldroyd, Alexander
    Sergeant, Jamie C.
    New, Paul
    McHugh, Neil J.
    Betteridge, Zoe
    Lamb, Janine A.
    Ollier, William E.
    Cooper, Robert G.
    Chinoy, Hector
    Ahmed, Yasmeen
    Armstrong, Raymond
    Bernstein, Robert
    Black, Carol
    Bowman, Simon
    Bruce, Ian
    Butler, Robin
    Carty, John
    Chattopadhyay, Chandra
    Chelliah, Easwaradhas
    Clarke, Fiona
    Dawes, Peter
    Devlin, Joseph
    Edwards, Christopher
    Emery, Paul
    Fordham, John
    Fraser, Alexander
    Gaston, Hill
    Gordon, Patrick
    Griffiths, Bridget
    Gunawardena, Harsha
    Hall, Frances
    Harrison, Beverley
    Hay, Elaine
    Horden, Lesley
    Isaacs, John
    Jones, Adrian
    Kamath, Sanjeet
    Kennedy, Thomas
    Kitas, George
    Klimiuk, Peter
    Knights, Sally
    Lambert, John
    Lanyon, Peter
    Laxminarayan, Ramasharan
    Lecky, Bryan
    Luqmani, Raashid
    Marks, Jeffrey
    Martin, Michael
    McGonagle, Dennis
    McHugh, Neil
    RHEUMATOLOGY, 2019, 58 (04) : 650 - 655
  • [48] Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
    Qian, Jinjing
    Li, Rui
    Chen, Zhiwei
    Cao, Zehui
    Lu, Liangjing
    Fu, Qiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort
    Koyoda, Sai K.
    Ezzy, Fatema
    Wahezi, Dawn
    Kumthekar, Anand
    Xie, Xianhong
    Tagoe, Clement E.
    Ayesha, Bibi
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [50] Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome
    Yang, L.
    Zhang, P.
    Yang, Q.
    Zhang, C.
    Guan, W.
    Liu, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 269 - 276
12345